Get started
Author

Kate Buccilli

OpenAlex ID: A5067904404
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
2024 · Cassandra M J Wannan, Barnaby Nelson, et al. · Schizophrenia Bulletin · 97
PDF
Development of the PSYCHS : Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS
2023 · Scott W. Woods, Sophie Parker, et al. · Early Intervention in Psychiatry · 65
PDF
A Sequential Adaptive Intervention Strategy Targeting Remission and Functional Recovery in Young People at Ultrahigh Risk of Psychosis: The Staged Treatment in Early Psychosis (STEP) Sequential Multiple Assignment Randomized Trial
2023 · Patrick D. McGorry, Cristina Mei, et al. · JAMA Psychiatry · 48
PDF
“When I’m Thinking Straight, I Can Put Things in Place for When I’m Not.” | Exploring the Use of Advance Statements in First-Episode Psychosis Treatment: Young People, Clinician, and Carer Perspectives
2020 · Lee Valentine, Dawson Grace, et al. · Community Mental Health Journal · 16
The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures
2025 · Daniel H. Mathalon, Spero Nicholas, et al. · Schizophrenia · 14
PDF
Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program
2025 · Jean Addington, Lu Liu, et al. · Schizophrenia · 13
PDF
Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia Program
2025 · Tashrif Billah, Kang Ik K. Cho, et al. · Schizophrenia · 10
PDF
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample
2025 · Kelly Allott, Walid Yassin, et al. · Schizophrenia · 10
Psychosis Risk: Time to Look Empirically at a First-step Economical-pragmatic Way to Examine Anomalous Self-experience. Exploring the SQuEASE-11
2024 · Paul Møller, Barnaby Nelson, et al. · Schizophrenia Bulletin · 7
Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program
2025 · Jean Addington, Lu Liu, et al. · Schizophrenia Bulletin Open · 6
PDF
Erythrocyte membrane fatty acid concentrations and myelin integrity in young people at ultra-high risk of psychosis
2024 · Melissa Collins, Cali Bartholomeusz, et al. · Psychiatry Research · 3
PDF
Premorbid adjustment problems, negative symptoms, and cognitive impairment in a large international sample at clinical high risk for psychosis: Findings from the Accelerating Medicines Partnership—Schizophrenia
2025 · Henry R Cowan, Danielle Pratt, et al. · Schizophrenia Bulletin · 2
Correction to: “When I’m Thinking Straight, I Can Put Things in Place for When I’m Not.” | Exploring the Use of Advance Statements in First-Episode Psychosis Treatment: Young People, Clinician, and Carer Perspectives
2020 · Lee Valentine, Dawson Grace, et al. · Community Mental Health Journal · 2
PDF
Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program
2025 · Jean Addington, Amy Shalev, et al. · Schizophrenia Bulletin Open · 1
PDF
Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra‐High Risk for Psychosis
2026 · Dulari Hakamuwa Lekamlage, Ling Min Amelia Ang, et al. · Early Intervention in Psychiatry
Relationship among Sleep Disturbance, Stress, and Suicidal Ideation in Clinical High Risk for Psychosis
2026 · Heather M Wastler, Aubrey Moe, et al. · Schizophrenia Bulletin Open
PDF
Works count: 16
Citation count: 294
H-index: 8
I10-index: 8
Year
Topic
Type